# Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients

> **NCT02252328** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University College, London** · enrollment: 50 (estimated)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02252328
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2018-08
- **Final completion:** 2019-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02252328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02252328, "Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02252328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*